Linde subsidiary Lincare is playing an active role in fighting the coronavirus (Covid-19) pandemic.
A leading provider of home respiratory care in the US, Lincare said it remains committed to ensuring continued care to 1.6 million patients across the US, supported by more than 2,000 Lincare clinicians; providing in-home services to patients with underlying chronic medical conditions who may be more vulnerable when contracting Covid-19; and helping to increase critical hospital capacity by transitioning respiratory patients and others from in-patients to in-home care.
Lincare said it is playing a critical role in caring for patients at home, including some who have tested positive for Covid-19.
The company is helping to ease the burden on hospitals across the country by partnering with them to transition patients who are eligible for in-home care, which results in additional hospital capacity for patients requiring critical care.
Lincare patients who have tested positive for Covid-19 have received respiratory services including oxygen and nebulised respiratory medications, as well as ventilation services.
“As a leader in the homecare industry, Lincare is taking all necessary steps to play an active role in fighting this pandemic as a trusted provider for our patients,” said Lincare CEO Crispin Teufel.
“This includes adhering to industry standards and protocols to help ensure the safety of our patients and our employees.”
“We stand with our fellow healthcare providers - doctors, nurses, caregivers, and clinical staff who are dedicated to providing an excellent standard of care to patients nationwide.”